US shifting COVID antivirals to commercial market on Nov. 1
By Ahmed Aboulenein WASHINGTON Most people will retain access to Pfizer's Paxlovid and Merck's Lagevrio COVID-19 oral antiviral
2023-10-28 04:16
Even Brief UAW Strike Seen Causing Billions in US Economic Damage
Just when US automakers and the broader economy were shaking off the effects of the pandemic and semiconductor
2023-09-11 03:50